A. S. Gerard-b, T. Bohman, and . D'incalci-m, Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma -an effective combination with unexpected toxicity, 1992.

, Eur. J. Cancer, vol.28, pp.447-450

. P. Albino-a and . Fountain-],

W. , Molecular genetics of human malignant melanoma, Cancer Treat. Res, vol.65, pp.201-255, 1993.

. Ausubel, Current Protocols in Molecular Biology, 1991.

. Ausubel, Current Protocols in Molecular Biology, 1991.

. Ausubel, Current Protocols in Molecular Biology, 1991.

. B. Baiaban-g, M. Herlyn, . H. Ciark-w, . Jr, and P. C. Nowell, Karyotypic evolution in human malignant melanoma, Cancer Genet. Cytogenet, vol.19, pp.113-122, 1986.

. Becher-r, Z. Gibas, C. Karakouris, and . A. Sandberg-a, Nonrandom chromosome changes in malignant melanoma, Cancer Res, vol.43, pp.5010-5016, 1983.

. T. Beck-w, Unknotting the complexities of multidrug resistance : the involvement of DNA topoisomerase in drug action and resistance, J. Natl Cancer Inst, vol.81, pp.1683-1685, 1989.

. T. Beck-w, Strategies to circumvent multidrug resistance due to Pglycoprotein or to altered DNA topoisomerase Il, Bull. Cancer, vol.77, pp.1131-1141, 1990.

. Benard-], ]. Bourhis, and . Riou-g, Clinical significance of multi drug resistance in human cancer, Anticancer Reasearch, vol.10, pp.1297-1302, 1990.

. Benson-d, . ]. Lipman-d, and . Ostellj, GenBank. Nucl. Acids Research, vol.21, pp.2963-2965, 1993.

C. Beppino, . C. Giovanelia-b, and . Foght-], The nude mouse in cancer reasearch, Advances in Cancer Reasearch, vol.44, pp.69-120

. Bergman-w, N. Gruis, and . Frants-r, Clinical and genetic patterns in dutch FAMM families, Symposium on the third International conference on melanoma, pp.31-34, 1993.

J. L. Biedler, Genetie aspects of multidrug resistance. Cancer suppl, vol.70, pp.1799-1809, 1992.

J. L. Biedler and . Riehm-h, Cellular resistance to actinomycin D in Chinese hamster ce11s in vitro : cross resistance radioautographic and cytogenetic studies, Cancer Res, vol.30, pp.117-121, 1970.

. M. Biack-s and . Wolf-r, The role of glutathione-dependent enzymes in drug resistance, Pharmacol. Ther, vol.51, pp.139-154, 1991.

C. Boaziz, Apport d'une nouvelle nitrosourée : la fotémustine, Path. Biol, vol.40, pp.964-968, 1992.

. Brunet-a, Traitement du mélanome malin disséminé, Path. Biol, vol.40, pp.960-963, 1992.

. K. Burt-r, . Garfield-d, . Johnson-k, and . Thorgeirsson-s, Transformation of rat liver epithelial cells with V-H-ras or V-H-raf causes expression of MDRl, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals, Carcinogenesis, vol.9, pp.2329-2332, 1988.

. Calvo-f and . De-cremoux-p, Gène de la résistance multidrogue MDRl, Bull. Cancer, vol.76, pp.973-977, 1989.

. M. Chaudhary-p and . B. Roninson-1, Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs, Journal of the National Cancer Institute, vol.85, pp.632-639, 1993.

C. D. Magnuson-v, B. Steffensen, and . J. Klebe-r, Use of stock solutions to simplify mRNA quantitation by reverse transcription-PCR assays, PCR Methods and applications, vol.2, p.353, 1993.

P. Chomczynski and . Sacchi-n, Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction, Anal. Biochem, vol.162, pp.156-159, 1987.

C. T. Drake-f, . Cohn-s, S. Per, S. Crooke, and . Mirabew-c, Characterisation and immunological identification of cDNA clones encoding two human DNA topoisomerase II isoenzymes, Proc. Natl Acad. Sei, vol.86, pp.9431-9435, 1989.

. S. Coates-a, Systemic chemotherapy for malignant melanoma, World J. Surg, vol.16, pp.277-281, 1992.

. Cocconi-g, Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. The New Engl, J. ofMed, vol.327, p.523, 1992.

. Coles-b and . Ketterer-b, The role of glutathione and Glutathione Transferases in chemical carcinogenesis, Biochem. Mol. Biol, vol.25, pp.47-70, 1990.

. C. Cosolo-w and . Christophidis-n, An Example of the Role of the Animal Model in Investigating New Techniques, Eur. J. Clin. Oncol, vol.25, pp.1511-1512, 1989.

. H. Cowan-k, . Bastit-g, . Tulpulea, . K. Sinha-b, and C. E. Myers, Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats, Proc. Natl. Acad. Sei. USA, vol.83, pp.9328-9332, 1986.

D. Porta and G. , Cellular and molecular biology of melanoma, Seminars in surgical Oncology, vol.8, pp.353-357, 1992.

V. V. De, . T. De-vita-v, S. Hellman, and . A. Rosenberg-s, Cancer : Principles and practice of oncology, Philadelphia: Llppincott, pp.276-300, 1989.

. C. Dracopou-n, P. Harne1t, and . ]. Bale-s, Lass of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression, Proc. Natl. Acad. Sei. USA, vol.86, p.4618, 1989.

M. Duguet, L. A. Venot-c, . Harper-f, G. Mirambeau, and . Derecondo-a.m,

, DNA Topo-isomerases from rat liver : physiological variations, vol.11, pp.1059-1075

G. Du and . Schuchter-lm, Disseminated melanoma -Is there a new standard therapy 7 The New Engl, J. of Med, vol.327, pp.560-561, 1992.

. Fairman-r and D. L. Brutlag, Expression of the Drosophila type II topoisomerase is developmentally regulated, Biochemistry, vol.27, pp.560-565, 1988.

. S)-ferre-f, Quantitative or semi-quantitative PCR : reality versus myth, PCR Methods and Applications, vol.2, pp.1-9, 1992.

. E. Flaherty-l, . Robinson-w, . G. Redman-b, . Gonzales-r, and . Martino-s,

M. Kraut, M. Valdivieso, and . R. Rudolph-a, A phase II study of dacarbazine and cisplatin in combination with outpatients administred interleukine-2 in metastatic malignant melanoma, Cancer, vol.71, pp.3520-3525, 1993.

. P. Flanagan-s, Nude" a new hair less gene with pleiotropic effects in the mouse, Genet. Res, vol.8, pp.295-301, 1966.

. T. Fojo-a, . Ueda-k, . J. Slamon-d, . G. Poplack-d, M. M. Gottesman et al., Expression of a multidrug-resistance gene in human tumors and tissues, Proc. Natl Acad. Sei. USA, vol.84, pp.265-269, 1987.

. A. Fryer-a, A. ]. Zhao-l, M. D. Boggld, W. Perrett, and . Clayton,

R. N. Jones-p and . C. Strange-r, The glutathione S-transferases : patients with pituitary adenomas, Carcinogenesis, vol.14, pp.563-566, 1993.

. C. Giovanella-b, J. S. Sterlin, . C. Shepard-r, and . Williams-l, , 1983.

, Correlation Between Reponse to Chemotherapy of Human Tumors in Patients and in Nude Mice, Cancer, vol.52, pp.1146-1152

. J. Goldstein-l, H. Galski, M. Willingham, G. A. Lai-s.l, . Pirker-r et al.,

. M. Gottesman-m and . Pastan-i, Expression of a multidrug resistance gene in human cancers, J. Natl Cancer lnst, vol.81, pp.116-124, 1989.

. Goldstein-lj, . Pastan-i, and M. M. Gottesman, Multidrug resistance in human cancer, Critical Rewiews in Oncology/Hematology, vol.12, pp.243-253, 1992.

. M. Gottesman-m, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem, vol.62, pp.385-427, 1993.

. D'après-gubler and . Hoffman-en, Molecular cloning of the CD2 antigen. The T-cell erythrocyte receptor, by a rapid immunoselection procedure, Proc. Natl. Acad. Sei. USA, vol.84, pp.3365-3369, 1983.

. S. Gupta-r, . Gupta-r, and . Eng-b, Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of Topoisomerase II, Cancer Res, vol.48, pp.6404-6410, 1988.

M. Gutman, M. Inbar, J. M. Kiausner, and . Chaitchik-s, Malignant melanoma in different ethnie groups in Israël, Cancer, vol.71, pp.2746-2750, 1993.

. Hansson-m, . Kârre-k, . Kif, . Sung-r, ]. Roder et al.,

, Natural NK-cell targets in the mouse thymus : characteristics of the sensitive cell population, J. Immunol, vol.123, pp.765-771

J. L. Harley and . Donelson-],

E. , Nature, vol.286, p.860, 1980.

H. A. Hochhauser-d, Mechanisms of multidrug resistance in cancer treatment, Acta Oncologica, vol.31, pp.205-213, 1992.

. B. Herberman-r, Natural cell-mediated cytotoxicity in nude mice. In : the nude mouse in experimental and clinical research, cds FOGH J, pp.135-141, 1978.

. B. Herberman-r, . E. Nunn-m, and D. H. Lavrin, Natural cytotoxicity reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors, 1975.

, Distribution ofreactivity and specificity, Int. J. Cancer, vol.16, pp.216-225

M. Heurre, D. Dubourdieu, P. Ravisse, C. S. Mc, and J. J. Floch,

M. G. Monchy, D. Baudin-r, . Herrmann-m, G. Falcoz, and . Crouzat-m,

. Bach-f, Le mélanome malin cutané en Nouvelle-Calédonie 1973-1991. Etude de 97 observations, Bull. Cancer, vol.80, pp.235-247, 1993.

P. A. Islam-m.q, C. Szpirer, G. Levan, and . Mannervik-b, , 1989.

, Chromosomal localization of human glutathione genes of classes alpha, mu and pi, Hum. Genet, vol.82, pp.338-342

. E. Ross-w, . M. Sullnan-d, . C. Chow-k, . T. De-vita-v, S. Hellman et al., Altered fonction of DNA Topoisomerase as a basis for antineoplastic drug action, pp.65-81, 1989.

R. L. Kramar-a and . Borden-e, Pronostic factors in metastatic melanoma, Cancer, vol.71, pp.2995-3005, 1993.

. K. Saiki-r, . H. Gelfand-d, S. Stoffel, . ]. Scharf-s, . Higuchi-r et al., Primer-directed enzymatic amplification of DAN with a thermostable DNA polymerase, Science, vol.239, pp.487-491, 1989.

Y. Saito, Y. Nakada, T. Hotta, T. Mikami, K. Kurisu et al.,

. Kiya-k, K. Kawamoto, and . Uozumi-t, Glutathione and cellular response of ACNU-resistant rat glioma sublines to drugs and radiation. lnt, J. Cancer, vol.48, pp.861-865, 1991.

. E. Salmon-s, . M. Grogan-t, . P. Miller-t, M. Lehnert, . S. Dalton-w et al., Clinical detection of multidrug resistance and reversai with chemosensitizing agents, pp.257-269, 1992.

S. Eds, . Fritsch, . Maniatis, and . Edmonds, Molecular Cloning, vol.1, 1971.

J. A. Sanchez and . A. Robinson-w, Malignant melanoma, Annu. Rev. Med, vol.44, pp.335-342, 1993.

J. Sehested, A simple method for R banding of human chromosomes, showing a pH-dependent connection between R and G bands, Humangenetik, vol.4, pp.55-58

. C. Shea-t, . L. Kelley-s, and W. D. Henner, Identification of an anionic form of Glutathione Transferase present in many human tumors and cell lines, Cancer Res, vol.48, pp.527-533, 1988.

G. Sozzi, M. Miozzo, and C. Calderone, Chromosome abnormalities and fragile sites in human melanoma, Cancer Genet. Cytogenet, vol.44, pp.61-67, 1990.

C. G. Steel-g and M. J. Peckham, The reponse to chemotherapy of a variety of human tumour xenografts, Br. J. Cancer, vol.47, pp.1-013, 1983.

. M. Suwvan-d, . S. Glisson-bb, . K. Hodges-p, . Smallwood-kentro-s, and . E. Ross-w, Proliferation dependance of Topoisomerase II mediated drug action, Biochemistry, vol.25, pp.2248-2256, 1986.

. Suzukake-k, . J. Petro-b, and D. T. Vistica, Reduction in glutathione content of L-PAM resistant L1210 cell confers drug sensitivity, Biochem. Pharmacol, vol.31, pp.121-124, 1982.

. B. Tan-k, . E. Dorman-t, . M. Falls-k, . D. Chung-t, C. K. Mirabelli et al., Topoisomerase Ila. and Topoisomerase II~ genes : characterization and mapping to human chromosomes 17 and 3, respectively, Cancer Res, vol.52, pp.231-234, 1992.

. B. Tan-k, M. R. Mattern, . K. Eng-w, . L. Mc-cabe-f, and . K. Johnson-r, Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors, J. Natl Cancer Inst, vol.81, pp.1732-1735, 1989.

. S. Tan-s and J. H. Weis, Development of a sensitive reverse transcriptase PCR assay, RT-PCR, utilizing rapid cycle times, PCR Methods and Applications, vol.2, pp.137-143, 1992.

. A. Teicher-b, . A. Holden-s, . J. Kelley-m, . C. Shea-t, C. A. Cucchi et al., Characterisation of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum, Cancer Res, vol.47, pp.388-393, 1987.

K. D. Tew, The role of Glutathions S Transferase in anticancer drug resistance, MIHICH E. Drug resistance : mechanisms and reversa!. Rome: John Llbbey CIC, pp.109-119, 1990.

. J. Townsend-a and . H. Cowan-k, Glutathione-S-Transferase and antineoplastic drug resistance, Cancer Bull, vol.41, pp.31-37, 1989.

J. M. Trent, . J. Stanbridge-f, and B. H. Mc, Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6, Science, vol.247, pp.568-571, 1990.

J. M. Trent, . H. Thompson-f, . L. Meyskens-f, and . Jr, Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma, Cancer Res, vol.49, pp.420-423, 1989.

T. J. Meyskens-f and . E. Salmon-s, Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma, New Engl. J. Med, vol.322, pp.1508-1513, 1980.